| Pretty Please Aesthetics
The SUSTAIN 8 study showed lean mass decreased 2.3 kg alongside total weight loss of 5.3 kg
DOI: Published online: April 25, 2016 Department of Internal Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea
Compounded semaglutide, which the FDA has allowed under shortage provisions and which sells for $100 to $200 per month, is not a patented product
Sublingual semaglutide is a compounded formulation, not the same as the FDA-approved oral semaglutide tablet (Rybelsus) that Novo Nordisk manufactures
The Dulaglutide mechanism of action is the same as any other GLP-1 receptor agonists mechanism of action mimicking the naturally occurring GLP-1 hormone, limiting blood sugar levels, preventing excessive glucose production, and promoting satiety